Voya Investment Management LLC Tricida, Inc. Transaction History

Voya Investment Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Mar 03, 2023	BUY	$8.51 - $13.6 $110,442 - $176,500	12,978 New	12,978 $136,000
Q2 2022 Aug 15, 2022	BUY	$7.31 - $11.85 $94,869 - $153,789	12,978 New	12,978 $126,000
Q2 2021 Aug 16, 2021	SELL	$3.95 - $5.41 $49,268 - $67,478	-12,473 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.37 - $9.46 $9,749 - $21,105	2,231 Added 21.78%	12,473 $88,000
Q2 2020 Aug 14, 2020	SELL	$21.21 - $31.55 $17,264 - $25,681	-814 Reduced 7.36%	10,242 $281,000

Q1 2020 May 15, 2020	BUY	$18.43 - $38.04 $9,583 - $19,780	520 Added 4.94%	11,056 $243,000
Q4 2019 Feb 14, 2020	BUY	$29.6 - $43.71 $67,665 - $99,921	2,286 Added 27.71%	10,536 $398,000
Q2 2019 Aug 14, 2019	BUY	$31.16 - $39.46 $49,201 - $62,307	1,579 Added 23.67%	8,250 $326,000
Q1 2019 May 15, 2019	BUY	$19.96 - $38.62 $133,153 - $257,634	6,671 New	6,671 $258,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.